Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Co-Diagnostics Inc (CODX)

Co-Diagnostics Inc (CODX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 85,952
  • Shares Outstanding, K 30,918
  • Annual Sales, $ 97,890 K
  • Annual Income, $ 36,660 K
  • 60-Month Beta -1.11
  • Price/Sales 0.91
  • Price/Cash Flow 2.26
  • Price/Book 0.72
Trade CODX with:

Options Overview Details

View History
  • Implied Volatility 102.79% ( -18.55%)
  • Historical Volatility 50.20%
  • IV Percentile 82%
  • IV Rank 37.59%
  • IV High 260.00% on 11/02/22
  • IV Low 8.09% on 07/13/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 169
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 14,992
  • Open Int (30-Day) 16,440

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.15
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year 0.25
  • Growth Rate Est. (year over year) -160.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.75 +0.36%
on 12/09/22
3.84 -28.12%
on 11/15/22
-0.60 (-17.73%)
since 11/09/22
3-Month
2.75 +0.36%
on 12/09/22
3.84 -28.12%
on 11/15/22
-0.51 (-15.60%)
since 09/09/22
52-Week
2.75 +0.36%
on 12/09/22
10.90 -74.68%
on 12/27/21
-5.85 (-67.94%)
since 12/09/21

Most Recent Stories

More News
Co-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 2.76 (-0.72%)
Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 2.76 (-0.72%)
CoDiagnostics, Inc. (CODX) Reports Q3 Loss, Lags Revenue Estimates

CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 33.33% and 24.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

CODX : 2.76 (-0.72%)
IONM : 0.4050 (+3.85%)
Co-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

CODX : 2.76 (-0.72%)
Co-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZ

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 2.76 (-0.72%)
Co-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific Officer

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 2.76 (-0.72%)
CO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

CODX : 2.76 (-0.72%)
Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

CODX : 2.76 (-0.72%)
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Co-Diagnostics, Inc. with Losses of $100,000 to Contact the Firm

/PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Co-Diagnostics, Inc....

CODX : 2.76 (-0.72%)
CO-DX DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Co-Diagnostics, Inc. (“Co-Dx” or the “Company”)...

CODX : 2.76 (-0.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology...

See More

Key Turning Points

3rd Resistance Point 2.98
2nd Resistance Point 2.94
1st Resistance Point 2.86
Last Price 2.76
1st Support Level 2.73
2nd Support Level 2.69
3rd Support Level 2.61

See More

52-Week High 10.90
Fibonacci 61.8% 7.79
Fibonacci 50% 6.82
Fibonacci 38.2% 5.86
Last Price 2.76
52-Week Low 2.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar